Study of PCUR-101 in Combination With ADT in Patients With mCRPC

NCT04677855 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Stopped Business Decision due to insufficient enrollment

Conditions

Prostate Cancer

Interventions

DRUG: PCUR-101
DRUG: Dutasteride 0.5 mg
DRUG: Abiraterone and Prednisone

Sponsor

Pellficure Pharmaceuticals, Inc